Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

Shortages of tirzepatide, sold as a diabetes drug (Mounjaro) and a weight-loss medication (Zepbound), have fueled demand for compounding pharmacies to make their own versions of the medicine, which ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Eli Lilly sues medical spas and vendors for selling unauthorized tirzepatide, the active ingredient in its weight-loss drug, Zepbound ... and promotion of products that imitate Mounjaro and Zepbound.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Mounjaro, the brand name for tirzepatide, is a drug that is used to treat type 2 diabetes by lowering blood sugar levels. It is approved for weight loss in the UK, however Ozempic isn’t licensed ...